Literature DB >> 19946293

Rheumatoid arthritis: the multifaceted role of adiponectin in inflammatory joint disease.

Ulf Müller-Ladner, Elena Neumann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19946293     DOI： 10.1038/nrrheum.2009.232

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Different effects of adiponectin isoforms in human monocytic cells.

Authors:  Markus Neumeier; Johanna Weigert; Andreas Schäffler; Gabriele Wehrwein; Ulf Müller-Ladner; Jürgen Schölmerich; Christian Wrede; Christa Buechler
Journal:  J Leukoc Biol       Date:  2006-01-24       Impact factor: 4.962

2.  A novel serum protein similar to C1q, produced exclusively in adipocytes.

Authors:  P E Scherer; S Williams; M Fogliano; G Baldini; H F Lodish
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

Review 3.  Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome.

Authors:  M E Trujillo; P E Scherer
Journal:  J Intern Med       Date:  2005-02       Impact factor: 8.989

4.  Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.

Authors:  Xiang-Hang Luo; Li-Juan Guo; Hui Xie; Ling-Qing Yuan; Xian-Ping Wu; Hou-De Zhou; Er-Yuan Liao
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

Review 5.  Adiponectin and adiponectin receptors.

Authors:  Takashi Kadowaki; Toshimasa Yamauchi
Journal:  Endocr Rev       Date:  2005-05       Impact factor: 19.871

6.  Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans.

Authors:  Jens M Bruun; Aina S Lihn; Camilla Verdich; Steen B Pedersen; Soren Toubro; Arne Astrup; Bjorn Richelsen
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-05-07       Impact factor: 4.310

7.  Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis.

Authors:  Jon T Giles; Matthew Allison; Clifton O Bingham; William M Scott; Joan M Bathon
Journal:  Arthritis Rheum       Date:  2009-09-15

8.  The potential of adiponectin in driving arthritis.

Authors:  Angela Ehling; Andreas Schäffler; Hans Herfarth; Ingo H Tarner; Sven Anders; Oliver Distler; Gisela Paul; Jörg Distler; Steffen Gay; Jürgen Schölmerich; Elena Neumann; Ulf Müller-Ladner
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

Review 9.  Adiponectin: A novel adipokine linking adipocytes and vascular function.

Authors:  Barry J Goldstein; Rosario Scalia
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

10.  Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.

Authors:  Trine Bay Laurberg; Jan Frystyk; Torkell Ellingsen; Ib T Hansen; Anette Jørgensen; Ulrik Tarp; Merete Lund Hetland; Kim Hørslev-Petersen; Nete Hornung; Jørgen Hjelm Poulsen; Allan Flyvbjerg; Kristian Stengaard-Pedersen
Journal:  J Rheumatol       Date:  2009-08-14       Impact factor: 4.666
  10 in total
  11 in total

1.  [Adiponectin as target in rheumatoid arthritis].

Authors:  E Neumann; K W Frommer; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2014-08       Impact factor: 1.372

2.  Visfatin/pre-B-cell colony-enhancing factor (PBEF), a proinflammatory and cell motility-changing factor in rheumatoid arthritis.

Authors:  Florian M P Meier; Klaus W Frommer; Marvin A Peters; Fabia Brentano; Stephanie Lefèvre; Dirk Schröder; Diego Kyburz; Jürgen Steinmeyer; Stefan Rehart; Steffen Gay; Ulf Müller-Ladner; Elena Neumann
Journal:  J Biol Chem       Date:  2012-07-05       Impact factor: 5.157

3.  Early Prediction of Clinical Response to Etanercept Treatment in Juvenile Idiopathic Arthritis Using Machine Learning.

Authors:  Xiaolan Mo; Xiujuan Chen; Chifong Ieong; Song Zhang; Huiyi Li; Jiali Li; Guohao Lin; Guangchao Sun; Fan He; Yanling He; Ying Xie; Ping Zeng; Yilu Chen; Huiying Liang; Huasong Zeng
Journal:  Front Pharmacol       Date:  2020-07-31       Impact factor: 5.810

4.  Ethnic-specific genetic analyses in rheumatoid arthritis: incremental gains but valuable contributions to the big picture.

Authors:  Maria I Danila; Richard J Reynolds; Hemant K Tiwari; S Louis Bridges
Journal:  Arthritis Rheum       Date:  2013-12

5.  Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study.

Authors:  A Gardette; S Ottaviani; J Sellam; F Berenbaum; F Lioté; A Meyer; J Sibilia; B Fautrel; E Palazzo; P Dieudé
Journal:  Clin Rheumatol       Date:  2016-01-22       Impact factor: 2.980

6.  A Prospective Follow-Up of Adipocytokines in Cohort Patients With Gout: Association With Metabolic Syndrome But Not With Clinical Inflammatory Findings: Strobe-Compliant Article.

Authors:  Sergio García-Méndez; Carolina Bustos Rivera-Bahena; José Luis Montiel-Hernández; Daniel Xibillé-Friedmann; Everardo Álvarez-Hernández; Ingris Peláez-Ballestas; Rubén Burgos-Vargas; Janitzia Vázquez-Mellado
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 7.  Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases).

Authors:  Elisa Gremese; Barbara Tolusso; Maria Rita Gigante; Gianfranco Ferraccioli
Journal:  Front Immunol       Date:  2014-11-11       Impact factor: 7.561

8.  Body mass index and treatment survival in patients with RA starting treatment with TNFα-inhibitors: long-term follow-up in the real-life METEOR registry.

Authors:  Sytske Anne Bergstra; Cornelia F Allaart; David Vega-Morales; Marieke De Buck; Elizabeth Murphy; Karen Salomon Escoto; Tom W J Huizinga
Journal:  RMD Open       Date:  2020-06

9.  Serum adiponectin as a predictor of laboratory response to anti-TNF-α therapy in rheumatoid arthritis.

Authors:  Dorota Sikorska; Rafał Rutkowski; Joanna Łuczak; Włodzimierz Samborski; Janusz Witowski
Journal:  Cent Eur J Immunol       Date:  2018-10-30       Impact factor: 2.085

10.  Body mass index influences the response to infliximab in ankylosing spondylitis.

Authors:  Sébastien Ottaviani; Yannick Allanore; Florence Tubach; Marine Forien; Anaïs Gardette; Blandine Pasquet; Elisabeth Palazzo; Marine Meunier; Gilles Hayem; Chantal Job-Deslandre; André Kahan; Olivier Meyer; Philippe Dieudé
Journal:  Arthritis Res Ther       Date:  2012-05-14       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.